Dennis J. Hartigan-O'Connor, Ph.D.
Affiliations: | 2003 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
muscle gene therapy, DMDGoogle:
"Dennis Hartigan-O'Connor"Parents
Sign in to add mentor| Jeffrey Chamberlain | grad student | 2003 | University of Michigan | |
| (Adenoviral vectors for treatment of Duchenne muscular dystrophy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Santos Rocha C, Hirao LA, Weber MG, et al. (2018) Subclinical cytomegalovirus infection associates with altered host immunity, gut microbiota and vaccine responses. Journal of Virology |
| Méndez-Lagares G, Lu D, Merriam D, et al. (2017) IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8(+) T Cell Responses in Acute Simian Immunodeficiency Virus Infection. Aids Research and Human Retroviruses. 33: S81-S92 |
| Merriam DP, Chen C, Mendez-Lagares G, et al. (2017) Depletion of gut-resident CCR5+ cells for HIV cure strategies. Aids Research and Human Retroviruses |
| Hartigan-O'Connor DJ, Jacobson MA, Tan QX, et al. (2011) Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 409-17 |
| Mi J, Barker S, Meuse L, et al. (2004) 460. Immunogenicity of E2b-Deleted Adenoviral Vectors Compared with First Generation Vectors Molecular Therapy. 9 |
| Mi J, Leuse L, Scott J, et al. (2004) 240. Immunogenicity of Dystrophins Delivered to Mice by Gutted Adenoviral Vectors Molecular Therapy. 9 |
| DelloRusso C, Scott JM, Hartigan-O'Connor D, et al. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proceedings of the National Academy of Sciences of the United States of America. 99: 12979-84 |
| Barjot C, Hartigan-O'Connor D, Salvatori G, et al. (2002) Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. The Journal of Gene Medicine. 4: 480-9 |
| Hartigan-O'Connor D, Chamberlain JS. (2002) Progress toward gene therapy of Duchenne muscular dystrophy. Seminars in Neurology. 19: 323-32 |
| Hartigan-O'Connor D, Barjot C, Salvatori G, et al. (2002) Generation and growth of gutted adenoviral vectors. Methods in Enzymology. 346: 224-46 |